TABLE 5.
Improvement associated with treatment (n=90)*
| Treatment | n (%) |
Improvement (n=74), n (%) |
|||
|---|---|---|---|---|---|
| None | Some | Complete | Unknown | ||
| No treatment | 38 (42.2) | 5 (13.2) | 7 (18.4) | 15 (39.5) | 11 (28.9) |
| Treatment | 52 (57.8) | 4 (7.7) | 17 (32.7) | 26 (50) | 5 (9.6) |
| PPI | 31 (34.4) | 3 (9.7) | 12 (38.7) | 12 (38.7) | 4 (12.9) |
| Triple therapy | 6 (6.7) | 0 | 1 (16.7) | 5 (83.3) | 0 |
| Triple therapy followed by PPI | 12 (13.3) | 0 | 3 (25) | 8 (66.7) | 1 (8.3) |
| H2-blockers | 1 (1.1) | 0 | 0 | 1 (100) | 0 |
| Various treatments | 2 (2.2) | 1 (50) | 1 (50) | 0 | 0 |
| Total | 90 (100) | 9 (10) | 24 (26.7) | 41 (45.5) | 16 (17.8) |
*
Four patients whose halitosis recurred are not included. PPI Proton pump inhibitor